Subject: CIIX Sub Featured in Wall Street Journal Article

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
CBD Biotech, Inc. part of the "CBD Boom in China"
Hot Stock to WatchHot Stock to Watch

Company:, Inc. (OTCQB: CIIX)


Price: 0.24

Change (%): - 0.01 (4.00)

Volume: 26,370
CIIX Chart, Inc.'s Subsidiary, CBD Boitech, Featured in Recent Wall Street Journal Report on the Growing Cannabis Industry in China

SAN GABRIEL, Calif., Nov. 25, 2019 /PRNewswire/ -, Inc. (OTCQB:CIIX) (“CIIX” or “the Company”), an established financial news and investment portal, as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced that its subsidiary CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands (“CBD Biotech”) was featured in a Wall Street Journal (the “Journal”) report on November 13, 2019, entitled “China Says No to Marijuana but Lets Its Cannabis Industry Bloom - Farmers, companies increase hemp-related investments; a push ‘at light speed’ into CBD business.”

As one of the first movers in the legal industrial hemp skincare and cosmetics market, we are honored to be featured in this recent Wall Street Journal report and believe that this mention validates our efforts in China over the past few years,” said Summer Yun, CEO of CBD Biotech, Inc.

According to the report, “The CBD Market will grow by 700% in the US this year and will be worth more than $23 billion by 2023.” China’s desire to obtain a piece of this growing market is evidenced by the ‘CBD Boom’ in China, focused in part on the export of pure CBD extract. The report also highlights CBD Biotech, a first mover in the industrial hemp skincare and cosmetics industry, working to educate consumers on the benefits of industrial hemp extract and positioning itself to be one of the leaders in China’s legal market for skincare and cosmetics infused with cannabis sativa leaf extract, industrial hemp extract.Although some components of marijuana are not allowed to be used in China, the extract of cannabis leaf used as a cosmetic raw material is legal and listed in the “Catalogue of Used Cosmetic Raw Materials” issued by the China Food and Drug Administration in 2015. Cannabis sativa leaf extract can legally be added to skincare and cosmetic products.

The article and accompanying video can be found at

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks